OBJECTIVE-We previously detected an association between a region of the estrogen receptor-␣ (ESR1) gene and type 2 diabetes in an African-American case-control study; thus, we investigated this region for associations with the metabolic syndrome and its component traits in African-American families from the Insulin Resistance Atherosclerosis Family Study.
RESEARCH DESIGN AND METHODS-A total of 17 single nucleotide polymorphisms (SNPs) from a contiguous 41-kb intron 1-intron 2 region of the ESR1 gene were genotyped in 548 individuals from 42 African-American pedigrees. Generalized estimating equations were computed using a sandwich estimator of the variance and exchangeable correlation to account for familial correlation.RESULTS-Significant associations were detected between ESR1 SNPs and the metabolic syndrome (P ϭ 0.005 to P ϭ 0.029), type 2 diabetes (P ϭ 0.001), insulin sensitivity (P ϭ 0.0005 to P ϭ 0.023), fasting insulin (P ϭ 0.022 to P ϭ 0.033), triglycerides (P ϭ 0.021), LDL (P ϭ 0.016 to P ϭ 0.034), cholesterol (P ϭ 0.046), BMI (P ϭ 0.016 to P ϭ 0.035), waist circumference (P ϭ 0.012 to P ϭ 0.023), and subcutaneous adipose tissue area (P ϭ 0.016).CONCLUSIONS-It appears likely that ESR1 contributes to type 2 diabetes and CVD risk via pleiotropic effects, leading to insulin resistance, a poor lipid profile, and obesity. Diabetes 56: 2135-2141, 2007